Related Experiment Video
Updated: Mar 3, 2026
07:32
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
2.1K
Biomarkers for Hepatocellular Carcinoma
Jiatao Lou1, LingFei Zhang2,3, Shaogang Lv1
1Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Biomarkers in Cancer
|May 5, 2017
Summary
Hepatocellular carcinoma (HCC) biomarkers aid in diagnosis and prognosis. This review explores current understanding of these vital biomarkers for liver cancer.
Area of Science:
- Oncology
- Biomarker Discovery
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern, ranking as the third leading cause of cancer mortality.
- Current diagnostic and prognostic strategies for HCC heavily rely on specific biomarkers.
- Biomarker combinations hold potential for guiding therapeutic interventions in HCC management.
Purpose of the Study:
- To provide a comprehensive review of the current knowledge regarding biomarkers for hepatocellular carcinoma (HCC).
- To highlight the role of biomarkers in HCC diagnosis, prognosis, and potential therapeutic strategies.
Main Methods:
- Literature review of existing research on HCC biomarkers.
- Synthesis of current understanding of biomarker applications in HCC.
Main Results:
- Biomarkers are crucial for accurate HCC diagnosis.
- Specific biomarkers assist in predicting patient prognosis.
- Combinations of biomarkers may inform therapeutic decisions for HCC.
Conclusions:
- Biomarkers are indispensable tools in the clinical management of HCC.
- Further research into HCC biomarkers can improve patient outcomes and treatment strategies.
